Although 30% of mucinous ovarian tumors (n = 104) had IHC performed for CK7, CK20, CDX2, SATB2, and PAX8 in a prior study (4), we were unable to perform this diagnostic panel on all cases and could not confirm whether they were done as part of routine pathologic assessment. Here, CDX2 is linked to ovarian mucinous neoplasm.